John Schilling is a Partner at TPG, where he leads the operations team for TPG Capital and co-leads TPG Capital’s healthcare investing practice. Additionally, John launched and co-leads TPG Life Sciences Innovations, the firm’s venture healthcare fund that seeks to invest in novel therapeutics, as well as digital health, medical devices, diagnostics, and tech-enabled services. Prior to joining TPG in 2011, John was a Corporate Officer at Abbott Laboratories, where he led sales and marketing for the ~$10B U.S. pharmaceutical business, and served as a Partner at McKinsey & Co., where he advised on healthcare strategy, M&A, and the commercialization of products and services. John received his undergraduate degree in biomedical and electrical engineering from Duke; a master’s in biomedical engineering from Johns Hopkins, where he was a Bozzelli Scholar; and an MD from the University of Chicago where he received the Joseph A. Capps Award for the most outstanding student in clinical medicine. John conducted his residency training in surgery at the Johns Hopkins Hospital and School of Medicine.